Clinical Efficacy of Cefoperazone/sulbactam for Acute Exacerbation of Chronic Obstructive Pulmonary Disease / 中华医院感染学杂志
Chinese Journal of Nosocomiology
;
(24)2009.
Article
in Chinese
| WPRIM
| ID: wpr-596696
ABSTRACT
OBJECTIVE To evaluate the clinical efficacy of cefoperazone/sulbactam(Sulperazon) for acute exacerbation of chronic obstructive pulmonary disease(AECOPD).METHODS A total of 136 cases of AECOPD were randomized into cefoperazone/sulbactam group and ceftazidime group,and sputum culture of each case was underwent before and after treatment.RESULTS The total efficacy rates and bacterial clearance rates in cefoperazone/sulbactam group and ceftazidime group were 91.18%,96.67% and 70.59%,75.86%,respectively,and the differences between the two groups were statistically significant.CONCLUSIONS It suggested that cefoperazone/sulbactam be a more effective drug for AECOPD.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Journal of Nosocomiology
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS